COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information

09/08/2018 - 22:43

Conference Call Scheduled for Friday, August 10th at 11:00 AM EDT NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]

MediPharm Labs Continues to Strengthen Leadership Team for Growth

09/08/2018 - 22:43

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Aug. 09, 2018 (GLOBE [...]

Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:30

AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s [...]

Denali Therapeutics Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today [...]

Terra Tech Corp Reports Financial Results for the Second Quarter of 2018

09/08/2018 - 22:20

IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its second quarter [...]

Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

09/08/2018 - 22:20

Investor Conference Call on Friday, August 10th at 10:00 am ET NEW YORK and CLEVELAND, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused [...]

Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results

09/08/2018 - 22:19

Macrilen™ (macimorelin) Successfully Launched in the U.S. in July CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing [...]

Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements

09/08/2018 - 22:17

-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis -- -- Established strategic mRNA vaccines partnership with Sanofi Pasteur -- -- Completed initial public offering raising approximately $ [...]

IntelGenx Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:17

SAINT LAURENT, Quebec, Aug. 09, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the second quarter ended June 30, 2018. [...]

ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:15

End-of-Phase 2 Meeting with the U.S. FDA on Gencaro Atrial Fibrillation Development Plan Completed; Single Additional Phase 3 Trial Planned to Support NDA Submission WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE [...]

Spero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview

09/08/2018 - 22:10

Pipeline continues to advance following recent positive data from SPR994 and Potentiator Platform; SPR994 Phase 3 initiation on-track to initiate around year-end Recent Follow-on Offering and BARDA award provide cash [...]

Asterias Biotherapeutics Reports Second Quarter Financial Results and Recent Development Progress

09/08/2018 - 22:10

Company Progressing Neurology and Immunotherapy Clinical Programs Anticipates Achievement of Significant Execution Milestones in the Second Half of 2018 and Full Year 2019 to Advance the Development of its Platform [...]

argenx to Present at 2018 Wedbush PacGrow Healthcare Conference

09/08/2018 - 22:06

Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

Kezar Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update

09/08/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR ), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]

The Joint Corp. Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:05

- Increases Annual System-Wide Gross Sales 29%, Compared to Second Quarter 2017 - - Grows Revenue 26%, Compared to Second Quarter 2017 - - Reports Net Loss of $43,000, Compared to Net Loss of $1.0 Million in Second [...]

ChemoCentryx Reports Second Quarter 2018 Financial Results and Recent Highlights

09/08/2018 - 22:05

-- Completed patient enrollment in Phase III ADVOCATE trial of avacopan in ANCA-associated vasculitis -- -- Ongoing clinical trials with avacopan in C3 Glomerulopathy (C3G) and CCX140 in Focal Segmental [...]

Yield10 Bioscience Announces Second Quarter 2018 Financial Results

09/08/2018 - 22:05

WOBURN, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]

BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results

09/08/2018 - 22:05

BELBUCA ® Continues Its Accelerated Record Prescription Growth of 80% YOY and 31% Versus the Prior Quarter Company Provides Overview of New Plan to Capitalize on Long Term Net Revenue Potential of $200 Million For [...]

Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results

09/08/2018 - 22:05

Conference Call Scheduled August 9, 2018 at 4:30 p.m. EDT BERKELEY HEIGHTS, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]